Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 27 of 27 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 10/09/19
Due: 10/09/20
Phase: N/A
Priority: Normal
Start: 04/19/19
End: 03/22/22
Due: 03/22/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) | NCT02927080 | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | user2@example.com | None | 2016-11-30 | 2019-10-09 | 2020-10-09 | - | - | 2025-07-14 |
| A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension | NCT03738150 | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | user2@example.com | None | 2019-04-19 | 2022-03-22 | 2023-03-22 | - | - | 2025-07-14 |